LudvigssonJF.Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr, 2020; 109:1088–1095.
2.
CastagnoliR, VottoM, LicariA, et al.Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review. JAMA Pediatr, 2020 [Epub ahead of print]; DOI: 10.1001/jamapediatrics.2020.1467.
VinerRM, WhittakerE.Kawasaki-like disease: emerging complication during the COVID-19 pandemic. Lancet, 2020 [Epub ahead of print]; DOI: 10.1016/S0140-6736(20)31129-6.
5.
BrambillaI, ToscaMA, De FilippoM, et al.Special issues for COVID-19 in children and adolescents. Obesity (Silver Spring) 2020 [Epub ahead of print]; DOI: 10.1002/oby.22878.
6.
LicciardiF, PruccoliG, DeninaM, et al. SARS-CoV-2-induced Kawasaki-like hyperinflammatory syndrome: a novel COVID phenotype in children. Pediatrics 2020 [Epub ahead of print]; DOI: 10.1542/peds.2020-1711.
7.
VerdoniL, MazzaA, GervasoniA, et al.An outbreak of severe Kawasaki-like disease at the Italian Epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet, 2020 [Epub ahead of print]; DOI: 10.1016/S0140-6736(20)31103-X.
8.
HendersonLA, CannaSW, SchulertGS, et al.On the alert for cytokine storm: immunopathology in COVID-19. Arthritis Rheumatol, 2020 [Epub ahead of print]; DOI: 10.1002/art.41285.
9.
PontaliE, VolpiS, AntonucciG, et al.Safety and efficacy of early high-dose IV Anakinra in severe COVID-19 lung disease. J Allergy Clin Immunol, 2020 [Epub ahead of print]; DOI: 10.1016/j.jaci.2020.05.002.
10.
PiccoloV, BassiA.Acral findings during the COVID-19 outbreak: chilblain-like lesions should be preferred to acro-ischemic lesions. J Am Acad Dermatol, 2020 [Epub ahead of print]; DOI: 10.1016/j.jaad.2020.05.077.
11.
GelardiM, TreccaE, CassanoM, et al.Smell and taste dysfunction during the COVID-19 outbreak: a preliminary report. Acta Biomed 2020 [Epub ahead of print]; DOI: 10.23750/abm.v91i2.9524.
12.
BunyavanichS, DoA, VicencioA.Nasal gene expression of Angiotensin-converting enzyme 2 in children and adults. JAMA, 2020 [Epub ahead of print]; DOI: 10.1001/jama.2020.8707.
13.
BrambillaI, CastagnoliR, CaimmiS, et al.COVID-19 in the pediatric population admitted to a tertiary referral hospital in Northern Italy: preliminary clinical data. Pediatr Infect Dis J, 2020 [Epub ahead of print]; DOI: 10.1097/INF.0000000000002730.
14.
LicariA, VottoM, CastagnoliR, et al.Allergy and asthma in children and adolescents during the COVID outbreak: what we know and how we could prevent allergy and asthma flares?. Allergy, 2020 [Epub ahead of print]; DOI: 10.1111/all.14369.
15.
ZhangJJ, DongX, CaoYY, et al.Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy, 2020 [Epub ahead of print]; DOI: 10.1111/all.14238.
16.
LindsleyAW, SchwartzJT, RothenbergME. Eosinophil responses during COVID-19 infections and coronavirus vaccination. J Allergy Clin Immunol, 2020; 146:1–7.
17.
JacksonDJ, BusseWW, BacharierLB, et al.Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor, ACE2. J Allergy Clin Immunol, 2020 [Epub ahead of print]; DOI: 10.1016/j.jaci.2020.04.009.
18.
HalpinDM, FanerR, SibilaO, et al.Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?. Lancet Respir Med, 2020 [Epub ahead of print]; DOI: 10.1016/S2213-2600(20)30167-3.
19.
CardinaleF, CiprandiG, BarberiS, et al.Consensus statement of the Italian Society of Pediatric Allergy and Immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic. Ital J Ped, 2020 [Epub ahead of print]; DOI: 10.1186/s13052-020-00843-2.